Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of Clostridium butyricum live drops for pediatric acute diarrhea
CTR20263386Phase 2Active
- Sponsor
- Hangzhou Grand Biologic Pharmaceutical Inc.
- Start
- Aug 2026
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of clostridium butyricum live drops in acute diarrhea, sponsored by Hangzhou Grand Biologic Pharmaceutical Inc.. Started Aug 2026; status: active.
02
Drugs
clostridium butyricum live drops
03
Conditions
acute diarrhea
Beyond the preview
Go deeper on CTR20263386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263386.